Reshaping Cultural Policies

ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results

Efficiency, Ramakanta Panda, Tax, Private Securities Litigation Reform Act, Form 10-K, Clinical trial, SAN, R, Security (finance), NASDAQ, Anatomy, Investor relations, Insurance, Risk, Growth, Depreciation, COVID-19, Overweight, Lists of diseases, Advertising, Annual report, EBITDA, Adjustable gastric band, Stomach, Acquisition, Company, U.S. Securities and Exchange Commission, Research, Awareness, GLOBE, Development, GAAP, Nature, Collection, Reshaping Cultural Policies, Weight loss, Marketing, Patient, FDA, Obesity, Medical device, Management, Risk management, Animal, Tutoring, Lithium, Pharmaceutical industry, Bank

SAN CLEMENTE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported its financial and operational results for the three and nine months ended September 30, 2021.

Key Points: 
  • SAN CLEMENTE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported its financial and operational results for the three and nine months ended September 30, 2021.
  • Third Quarter Ended September 30, 2021 and 2020 Financial Highlights
    Revenue for the three months endedSeptember30, 2021was$3.7millioncomparedto $3.6million in revenue for the three months endedSeptember30, 2020.
  • This reflects another period of consecutive sequential growth in 2021 at 5.1% for the quarter.
  • Further, the non-GAAP financial measures presented by the Company may be different from similarly named non-GAAP financial measures used by other companies.

ReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021

Ramakanta Panda, Private Securities Litigation Reform Act, SAN, Security (finance), NASDAQ, Anatomy, Investor relations, Risk, Lists of diseases, Forward-looking statement, Annual report, Stomach, U.S. Securities and Exchange Commission, GLOBE, Awareness, Collection, Reshaping Cultural Policies, Weight loss, Patient, FDA, Obesity, Medical device

SAN CLEMENTE, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced today that it will report its third quarter 2021 financial and operational results on Thursday, November 11, 2021 at 8:30 a.m.

Key Points: 
  • SAN CLEMENTE, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced today that it will report its third quarter 2021 financial and operational results on Thursday, November 11, 2021 at 8:30 a.m.
  • Management will post a webinar to discuss ReShape's financial results at 8:45 a.m.
  • The link to the webinar will be available on the Investor Relations page of the ReShape Lifesciences, Inc. website, https://ir.reshapelifesciences.com/ .
  • ReShape Lifesciences is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease.

Blank Street, the High-Growth, Small-Format and Tech-Forward Coffee Company Secures $25 Million in Series A Funding

Retrieved on: 
Wednesday, October 13, 2021
Momentum, DUMBO, KDT, Street, Time, Catalysis, Growth, General Catalyst, NEW, Harvard Business School, Friends, Coffee, Technology, National Medal of Technology and Innovation, Tiger Global Management, Founder, Student, GLOBE, Washington Square Park, Reshaping Cultural Policies, NYU, Partnership, Hey Tea, Culture, Starbucks, HubSpot, Menda, Nightclub, Online shopping

NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Blank Street, the high-growth, small-format specialty coffee company born in Brooklyn, NY today announced a $25 million Series A investment led by General Catalyst and Tiger Global, along with additional strategic investors including Neil Blumenthal and Dave Gilboa (Founders, Warby Parker), Jeff Raider (Founder, Warby Parker and Harry’s), Joey Zwillinger (Founder, Allbirds) and global real estate firm Tishman Speyer. Following a $7M Seed raise earlier this year, the new Series A funding will help fuel Blank Street’s rapid retail expansion, with a focus on evolving its vendor partnerships and technology capabilities.

Key Points: 
  • In August 2020, Blank Street debuted its first location, a mobile coffee cart, at the iconic Wythe Diner in Williamsburg.
  • Blank Street has quickly established itself as the newest contender in NYCs high-growth specialty coffee race, says Youngme Moon, newly named Blank Street board member and notable Harvard Business School professor.
  • I look forward to being on this journey with the entire Blank Street team as they continue their expansion throughout NYC and across the U.S.
  • The company will debut this new model with Brooklyn-based King David Tacos (KDT), where KDTs coveted breakfast tacos will be served alongside Blank Streets coffee and tea drinks.

ReShape Launches National Advertising Campaign for Flagship Product, Lap-Band®

People, NASDAQ, Private Securities Litigation Reform Act, Reshaping Cultural Policies, TLC, Us Weekly, Company, Public relations, Insurance, American Psychological Association, National, Forward-looking statement, Publication, BMI, Adult, Form 10-K, SAN, HGTV, Ramakanta Panda, COVID-19, The Harris Poll, Collection, GLOBE, Good Housekeeping, Mortality, Stomach, Population, Adjustable gastric band, Research, Anatomy, FDA, India Reloaded: Inside India's Resurgent Consumer Market, U.S. Securities and Exchange Commission, Weight loss, Aftercare, Quality of life, Woman, Security (finance), Harris, Annual report, Lists of diseases, Weight gain, CEO, Awareness, TV Guide, Â, Patient, Risk, FOX, Overweight, Social media, Obesity, Bravo, Pharmaceutical industry

SAN CLEMENTE, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) --  ReShape Lifesciences Inc. (NASDAQ: RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced the launch of a multi-platform consumer advertising campaign utilizing national television, print, social media, and public relations to market their Next-Generation Lap-Band® Program with available aftercare supported through reshapecare™, their reimbursable virtual health coaching platform to create consumer awareness and increase patient demand.

Key Points: 
  • ReShape Lifesciences has designed this national campaign to build Lap-Band brand awareness and a call to action for people seeking a personalized and effective weight-loss program that places control in the hands of the patient without a drastic change in their daily lifestyle.
  • With over two decades of data, the adjustable and reversible Lap-Band has demonstrated lower complication and mortality rates compared to other surgical weight-loss procedures.
  • Based on those metrics, we are confident that targeted national advertising on this major scale will highlight the exclusive benefits of the Lap-Band, driving higher procedural volumes and corresponding revenues, commented Bart Bandy, President and CEO at ReShape Lifesciences.
  • The recently launched ReShape Marketplace is an online collection of quality wellness products curated for all consumers to help them achieve their health goals.

ReShape Lifesciences™ to Host Exhibit at Bariatric Summit

Risk, CAGS, U.S. Securities and Exchange Commission, Security (finance), Lists of diseases, SAN, Stomach, Form 10-K, FDA, Health, Forward-looking statement, LD, Weight loss, Patient, Company, Private Securities Litigation Reform Act, Anatomy, Annual report, NASDAQ, Reshaping Cultural Policies, Obesity, RDN, Collection, GLOBE, MetroCentre, Ramakanta Panda, Pharmaceutical industry, Risk management, Bridge

SAN CLEMENTE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the company will host an exhibit at the upcoming 17th Annual Bariatric Summit in Washington, D.C. September 18-19, 2021.

Key Points: 
  • SAN CLEMENTE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss solutions company, today announced the company will host an exhibit at the upcoming 17th Annual Bariatric Summit in Washington, D.C. September 18-19, 2021.
  • ReShape Senior Director of reshapecare Heather Mackie, MS, RDN, LD will be presenting and participating in focal patient care sessions during the conference.
  • We look forward to engaging in actionable discussions among the prestigious physician and integrated health community members at the upcoming Bariatric Summit.
  • We encourage participants to attend Heathers presentations and visit our exhibit to learn more about ReShapes Physician-Led Weight Loss Solutions and forward strategy, commented Bart Bandy, President and Chief Executive Officer at ReShape Lifesciences.